---
title: "NKF's subsidiary has obtained the US FDA's registration approval for the transfer of the production site of Etoposide Injection"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249532776.md"
description: "NKF's subsidiary Meitheal Pharmaceuticals, Inc. recently received approval from the U.S. FDA, allowing Jianjin Pharmaceutical Co., Ltd. to produce Etoposide Injection (100 mg/5 mL, 500 mg/25 mL, and 1 g/50 mL). The new product will be launched in the U.S. soon and is expected to have a positive impact on the company's performance"
datetime: "2025-07-22T08:29:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249532776.md)
  - [en](https://longbridge.com/en/news/249532776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249532776.md)
generator: "portal-rs"
---

# NKF's subsidiary has obtained the US FDA's registration approval for the transfer of the production site of Etoposide Injection

According to the Zhitong Finance APP, Jianyou Co., Ltd. (603707.SH) announced that its subsidiary Meitheal Pharmaceuticals, Inc. (referred to as "Meitheal") recently received a site transfer approval letter from the U.S. Food and Drug Administration (referred to as "U.S. FDA") for Etoposide Injection, 100 mg/5 mL, 500 mg/25 mL, and 1 g/50 mL, multi-dose (ANDA No.: 074529), allowing production at the site of its subsidiary Jianjin Pharmaceutical Co., Ltd.

The newly approved product is scheduled to be launched in the U.S. soon, which is expected to have a positive impact on the company's operating performance

### Related Stocks

- [603707.CN](https://longbridge.com/en/quote/603707.CN.md)

## Related News & Research

- [20:00 ETWuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion](https://longbridge.com/en/news/297441220.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology](https://longbridge.com/en/news/297642626.md)
- [Tezos to Launch Post-Quantum Testnet in September](https://longbridge.com/en/news/297946567.md)
- [Chandra Asri unit Chandra Pelabuhan Nusantara opens port terminal to third-party users after license win](https://longbridge.com/en/news/297732068.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**